Aubrey Rankin, President, Innovation & Technology at Revance Therapeutics, Inc. (RVNC), sold 54,332 shares at $30.15 ($1.6M) on 2021-07-28, disclosed to the SEC on 2021-07-30.
Open-market sale of $1.6M RVNC by President, Innovation & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.00 | 34,332 | $1.0M | 63.1% |
| 2 | $30.15 | 20,000 | $603K | 36.9% |
| Total | $30.06 avg | 54,332 | $1.6M | 100% |
| Filing → |
| RVNC | SELL | 2021-07-28 | $3.3M | — | Filing → |
| RVNC | SELL | 2021-04-06 | $57 | — | Filing → |
| RVNC | SELL | 2021-03-05 | $1.7M | — | Filing → |